Global Ocular Implants Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type (Intraocular Lenses, Ocular Prosthesis, Others), By End Users (Eye Hospitals, Ophthalmic Clinics, Eye Institutes), And By Geography - Forecasts From 2021 To 2026

The global ocular implants market is expected to grow at a CAGR of 9.92% reaching a market size of US$32.153 billion in 2029 from US$16.582 billion in 2022.

The main factor expected to drive the market is the rising prevalence of eye conditions like scleritis, cataracts, glaucoma, and age-related macular degeneration. The need for surgical procedures involving ocular implants is increasing as a result of the incidence rate increase. This is primarily ascribed to the increasing developments in ophthalmic diagnostic technology as well as the accessibility of online resources that inform the public about available treatment options. Furthermore, this has resulted in a rise in the usage of sophisticated eye devices like glaucoma and artificial eye devices. Ocular implant technological developments are a major factor propelling the worldwide market.

Rising demand of glaucoma implants

The market growth can be attributed to the fact that glaucoma is becoming more common and is one of the main causes of blindness. A Bright Focus Foundation study estimates that 20 million individuals worldwide suffered from glaucoma in 2020. By the end of 2040, it is anticipated that this number will surpass 111 million. The ocular implants market is divided into intraocular lenses, corneal implants, orbital implants, glaucoma implants, ocular prostheses, and other categories based on the type of product. Over the course of the forecast period, glaucoma implants are expected to continue to increase the market demand. This is because governmental and non-governmental organizations have raised awareness of glaucoma. For example, to raise awareness about glaucoma, the World Glaucoma Association has launched an initiative called "World Glaucoma Week," which is scheduled to take place from March 6–12, 2022. Moreover, they have been used for so long to treat nearsightedness, farsightedness, and presbyopia, intraocular lenses have become increasingly popular.

Increasing importance of aesthetic value has led to a rise in the adoption of ocular prosthesis

For those who have experienced eye trauma, the ocular prosthesis adds aesthetic value to their faces. The market offers a wide range of implantable ocular prostheses composed of scleral shell, acrylic, and glass. The use of cryolite glass ocular prostheses is becoming more and more popular. This is because the glass provides a reflection that resembles the human eye. Furthermore, the development of digital technology has made it possible to quickly and accurately construct an ocular prosthesis of this kind. In developed nations like the United States, Germany, and Japan, the acceptance of glass ocular prostheses has shifted as a result of these factors.

Increasing prevalence of eye disorders like cataract and glaucoma

The two most common ocular conditions affecting the world's elderly population are cataract and glaucoma. The World Health Organization (WHO) estimates that cataracts cause blindness in about 20 million people globally. Furthermore, it is estimated that only 17% of people with cataract-related vision impairment and 36% of people with refractive error-related distance vision impairment worldwide have access to the proper interventions. The glaucoma devices and intraocular lenses have become more popular as a result of this increase. The population's growing awareness of various treatment options in conjunction with the aforementioned factors is expected to support the growth of the ocular implants market in the foreseeable future.

Rising technological advancements

There have been many technological developments in the market. For example, PRIMA System, a bionic or artificial eye technology that partially replaces the physiological function of the eye's photoreceptors, was recently introduced by PIXIUM VISION. A wireless sub-retinal implant that sends visual data to the brain's optical nerve makes this possible. The gadget also includes a digital projector, a pair of glasses with a camera integrated into them, and a pocket processor. A feasibility study for this technology is presently being conducted in the United States and France for people with age-related macular degeneration (dry atopic form), which causes severe vision loss. Furthermore, the development of microinvasive glaucoma devices for glaucoma patients is anticipated to propel the market. Advanced intraocular lenses and corneal implants that solve issues with currently available implantable devices are two more examples of such innovations. During the projected years, it is anticipated that the market sales of these cutting-edge technologies for treating ocular disorders and diseases will soar.

High demand of ocular implants in the hospitals

This is because more patients choose to have eye surgeries done in hospitals than in clinics or other settings. Two of the factors driving the growth of the hospital segment are the rising prevalence of cataract and glaucoma surgeries in hospitals, as well as the growing number of people undergoing ocular surgeries. The need for ocular implants in hospitals is expected to be fueled by other significant factors, such as the developing healthcare infrastructure in developing nations and the rise in the number of sophisticated healthcare facilities. By the end of the forecast period, it is anticipated that this market trend will be followed.

North America is witnessing exponential growth during the forecast period

North America is anticipated to grow at a high rate because of the rising incidence of eye problems, sedentary lifestyles, and rising knowledge of important factors. The factors that are primarily driving the market boom in North America are Trelease products. Additionally, the region's access to technologically advanced products and a favourable pay environment are factors that may make it likely for the company to maintain its lead over the course of the forecast period.

Market key launches

• In February 2024, leading global provider of eye health care, Johnson & Johnson MedTech*, has announced that the TECNIS PureSee purely refractive presbyopia-correcting lens is now offered in Europe. Similar to a monofocal IOL, the TECNIS PureSee IOL has a purely refractive design that is proprietary and provides continuous, high-quality vision with high best-in-category contrast and low-light performance.
• In December 2023, The FDA approved Glaukos Corp.'s New Drug Application (NDA) for travoprost intracameral implant (iDose TR) 75 mcg, a prostaglandin analogue indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). The travoprost intracameral implant, according to Glaukos Corp.1, is a long-duration intracameral pharmaceutical therapy intended to provide therapeutic levels of a unique formulation of travoprost inside the eye for prolonged periods.

Segmentation:

• By Type
  • Intraocular lenses
  • Ocular Prostheses
  • Others
• By End-User
  • Eye Hospitals
  • Ophthalmic Clinics
  • Eye Institutes
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Others